DF
MRTX

Donoghue Forlines’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Donoghue Forlines’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,260
Closed -$1.7M – 306
2020
Q3 		$1.7M Buy
+10,260
New +$1.7M 0.47% 27